Reader Engagement Helps Us Fulfill Our Mission … And Feel Good, Too
A few years ago I met Mark Scharenbroich. Thankfully, the award-winning author of Nice Bike — Making Meaningful Connections on the Road of Life ended up contributing a Leadership Lessons article for Life Science Leader magazine.
Continue Reading..
Leadership Lessons From Chris Ruisi — Author Of "Step Up And Play Big"
We’ve all probably encountered the frustrations related to flight delays and cancellations. I recently experienced the latter while on my way to the 35th Annual J. P. Morgan Healthcare Conference (commonly referred to as JPM) in San Francisco. Although, one positive did come out of my unplanned delay — it afforded me the opportunity to get through a leadership book I had been meaning to read, Step Up And Play Big by Chris Ruisi.
Continue Reading..
Despite Delays, JPM 2017 Still Pays Off For Me
For the second year in a row my travel plans to the biopharmaceutical industry’s yearly kickoff event — the 35th Annual J. P. Morgan Healthcare Conference in San Francisco — were disrupted by weather. And though I once again arrived a day late, there was still plenty to keep me busy during JPM.
Continue Reading..
Why “Partnering For Cures” Is A Highly Differentiated Experience
Two weeks ago I went to the Partnering For Cures (Nov. 13 – 15) conference at the Grand Hyatt in New York. After the experience, it is almost painful to admit that this was my first time attending. Developed by Faster Cures and the Milken Institute, the conference (now in existence for over eight years) brings together nearly 1,000 leaders from across the research ecosystem. The event’s goal is to forge partnerships dedicated to...
Continue Reading..
Trump Wins: What Can Pharma Hope For In The Next 4 Years?
On November 14, 2016, Carolyn Johnson posted “Trump just dropped a big hint to the pharmaceutical industry” in a wonkblog for The Washington Post. I shared the article on LinkedIn (receiving over 415 views) noting, “It is very early days, so let’s not get too excited or too concerned. But let’s be aware and strive to be part of the solution for helping patients.” This seemed like a natural fit to share...
Continue Reading..
6 Lessons Learned From Posting A Picture That Went Viral On LinkedIn
A little over a week ago, I posted a picture to my LinkedIn profile, which has since received over 60,000 views. And while there are mathematical calculations to officially determine when a post has gone viral, the fact that it has been viewed (and commented on) more widely than anything I have ever previously published is very humbling, especially considering the nature of the photo (i.e., a fallen U.S. service member) is far outside of what I...
Continue Reading..
How The Biopharmaceutical Industry Provides A Sparkle Of Hope
Author Steven Covey’s famous phrase, “To Live, To Love, To Learn, To Leave a Legacy” is what popped into my head while attending the Community of Hope’s Annual Dinner Auction as the invited guest of pharmaceutical industry icon, Fred Hassan. Twenty years ago Hassan founded this annual charity event that brings together two communities (i.e., social services and the biopharmaceutical industry) to do good in their own...
Continue Reading..
Will Cuba Be The World’s Next Leading Biotech Hub?
Life Science Leader magazine was recently invited to attend The Economist’s War On Cancer healthcare forum in Boston, Sept. 28, 2016. Though all of the day’s sessions were intriguing, the one that got me up out of my chair to track down a speaker before his exit occurred at 4 p.m. Entitled, “Going Global – Examples Of Cancer Advances From Around The World,” the first person to speak was Kelvin Lee, M.D., immunology...
Continue Reading..
What I Found Enlightening About ISPE’s Annual Meeting
Have you ever attended a meeting and gotten the sense of being enlightened during someone’s presentation? I recently had such an experience at the International Society for Pharmaceutical Engineering (ISPE) annual meeting and expo in Atlanta, GA. But it was neither where I expected it, nor whom I expected it from (e.g.,, keynote speakers). Don’t get me wrong, Joseph Jimenez, Dr. Stephan Grupp, M.D., Ph.D., Nicole Pierson, and Fleming...
Continue Reading..
Beyond IPOs: Alternative Funding Options For Biotech Startups
“While it is great when Morgan Stanley, JP Morgan, and Goldman are fighting to take your company public, sometimes, given the investment environment, you have to play in a ‘less elegant’ part of the finance swimming pool (e.g., Form 10s and reverse mergers).” This statement by Aftab Kherani, M.D., a partner at Aisling Capital, was made in response to the question, “What are some of the more innovative ways companies...
Continue Reading..
Rob Wright
Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL
This website uses cookies to ensure you get the best experience on our website. Learn more